{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T19:10:49Z","timestamp":1776712249896,"version":"3.51.2"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00595-025-03154-3","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:36:18Z","timestamp":1760542578000},"page":"445-454","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Feasibility and outcomes of curative-intent surgery for clinically node-positive non-small cell lung cancer with interstitial lung disease"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8812-1787","authenticated-orcid":false,"given":"Masatoshi","family":"Kanayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hina","family":"Jojiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumasa","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Chikaishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"3154_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1378\/chest.14-0359","volume":"147","author":"S Tomassetti","year":"2015","unstructured":"Tomassetti S, Gurioli C, Ryu JH, De Biase D, Ravaglia C, Tantalocco P, et al. The impact of lung cancer on survival of idiopathic pulmonary fibrosis. Chest. 2015;147:157\u201364.","journal-title":"Chest"},{"key":"3154_CR2","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1097\/JTO.0b013e318216ee6b","volume":"6","author":"H Kenmotsu","year":"2011","unstructured":"Kenmotsu H, Naito T, Kimura M, Ono A, Shukuya T, Nakamura Y, et al. The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer. J Thorac Oncol. 2011;6:1242\u20136.","journal-title":"J Thorac Oncol"},{"key":"3154_CR3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/JTO.0000000000000359","volume":"10","author":"N Ueki","year":"2015","unstructured":"Ueki N, Matsuo Y, Togashi Y, Mizowaki T, Nakamura M, Ishii K, et al. Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer. J Thorac Oncol. 2015;10:116\u201325.","journal-title":"J Thorac Oncol"},{"key":"3154_CR4","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1016\/j.chest.2022.02.057","volume":"162","author":"S Ikeda","year":"2022","unstructured":"Ikeda S, Misumi T, Kato T, Okamoto H, Ogura T. Immune checkpoint inhibitor-induced pneumonitis in patients with non-small cell lung cancer and preexisting interstitial lung diseases: really mild and easily manageable? Chest. 2022;162:e65\u20136.","journal-title":"Chest"},{"key":"3154_CR5","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.jtcvs.2013.09.050","volume":"147","author":"T Sato","year":"2014","unstructured":"Sato T, Teramukai S, Kondo H, Watanabe A, Watanabe T, Yokoi K, et al. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. J Thorac Cardiovasc Surg. 2014;147:1604-11.e3.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3154_CR6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s11748-014-0487-6","volume":"63","author":"T Sato","year":"2015","unstructured":"Sato T, Kondo H, Watanabe A, Okubo K, Yokoi K, Nakagawa K. A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patients. Gen Thorac Cardiovasc Surg. 2015;63:164\u201372.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"3154_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/0218492318816229","volume":"27","author":"M Kanayama","year":"2019","unstructured":"Kanayama M, Osaki T, Nishizawa N, Nakagawa M, So T, Kodate M. Modified risk scoring system for acute exacerbation of interstitial lung disease. Asian Cardiovasc Thorac Ann. 2019;27:18\u201322.","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"3154_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jtcvs.2014.08.086","volume":"149","author":"T Sato","year":"2015","unstructured":"Sato T, Watanabe A, Kondo H, Yokoi K, Nakagawa K, Okubo K, et al. Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases. J Thorac Cardiovasc Surg. 2015;149:64\u20139.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3154_CR9","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.athoracsur.2016.05.094","volume":"102","author":"T Iwata","year":"2016","unstructured":"Iwata T, Yoshida S, Fujiwara T, Matsumoto S, Matsuno Y, Miyamoto Y. Effect of perioperative pirfenidone treatment in lung cancer patients with idiopathic pulmonary fibrosis. Ann Thorac Surg. 2016;102:1905\u201310.","journal-title":"Ann Thorac Surg"},{"key":"3154_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00595-019-01923-5","volume":"50","author":"M Kanayama","year":"2020","unstructured":"Kanayama M, Mori M, Matsumiya H, Yamamoto Y, Inoue M, Tsubochi H. Perioperative pirfenidone treatment for lung cancer patients with idiopathic pulmonary fibrosis. Surg Today. 2020;50:469\u201374.","journal-title":"Surg Today"},{"key":"3154_CR11","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.21037\/jtd-22-535","volume":"15","author":"Y Sakairi","year":"2023","unstructured":"Sakairi Y, Yoshino I, Iwata T, Tsuboi M, Okada M, Yano T, et al. A randomized controlled phase III trial protocol: perioperative pirfenidone therapy in patients with non-small cell lung cancer combined with idiopathic pulmonary fibrosis. J Thorac Dis. 2023;15:1486\u201393.","journal-title":"J Thorac Dis"},{"key":"3154_CR12","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.jtcvs.2017.03.116","volume":"154","author":"Y Tsutani","year":"2017","unstructured":"Tsutani Y, Mimura T, Kai Y, Kobayashi M, Matsui H, Nishikubo M. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease. J Thorac Cardiovasc Surg. 2017;154:1089-96.e1.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3154_CR13","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1093\/jjco\/hyaa092","volume":"50","author":"K Tanaka","year":"2020","unstructured":"Tanaka K, Tsutani Y, Wakabayashi M, Kobayashi M, Matsui H, Oizumi H, et al. Sublobar resection versus lobectomy for patients with resectable stage I non-small cell lung cancer with idiopathic pulmonary fibrosis. Jpn J Clin Oncol. 2020;50:1076\u20139.","journal-title":"Jpn J Clin Oncol"},{"key":"3154_CR14","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.jtho.2023.10.012","volume":"19","author":"J Huang","year":"2024","unstructured":"Huang J, Osarogiagbon RU, Giroux DJ, Nishimura KK, Bille A, Cardillo G, et al. The international association for the study of lung cancer staging project for lung cancer: proposals for the revision of the N descriptors in the forthcoming ninth edition of the TNM classification for lung cancer. J Thorac Oncol. 2024;19:766\u201385.","journal-title":"J Thorac Oncol"},{"key":"3154_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg"},{"key":"3154_CR16","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thompson BT, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: An official clinical practice guideline. Am J Respir Crit Care Med. 2022;205:e18-47.","journal-title":"Am J Respir Crit Care Med"},{"key":"3154_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","volume":"194","author":"HR Collard","year":"2016","unstructured":"Collard HR, Ryerson CJ, Corte TJ, Richeldi L, Inoue Y, Molina-Molina M, et al. Acute exacerbation of idiopathic pulmonary fibrosis: an international working group report. Am J Respir Crit Care Med. 2016;194:265\u201377.","journal-title":"Am J Respir Crit Care Med"},{"key":"3154_CR18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jtho.2018.10.002","volume":"14","author":"J Okami","year":"2019","unstructured":"Okami J, Shintani Y, Okumura M, Aokage K, Tsuboi M, Asamura H, et al. Demographics, safety and quality, and prognostic information in TNM classifications in 18,973 cases. J Thorac Oncol. 2019;14:212\u201322.","journal-title":"J Thorac Oncol"},{"key":"3154_CR19","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1016\/j.cllc.2022.10.003","volume":"24","author":"MS Ki","year":"2023","unstructured":"Ki MS, Kim SY, Kim EY, Lee J, Chung MP, Park K. Clinical outcomes and prognosis of patients with interstitial lung disease undergoing lung cancer surgery. Clin Lung Cancer. 2023;24:e27-38.","journal-title":"Clin Lung Cancer"},{"key":"3154_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255375","volume":"16","author":"H Alomaish","year":"2021","unstructured":"Alomaish H, Ung Y, Wang S, Tyrrell PN, Zahra SA, Oikonomou A. Survival analysis in lung cancer patients with interstitial lung disease. PLoS ONE. 2021;16:e0255375.","journal-title":"PLoS ONE"},{"key":"3154_CR21","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1440-1843.2011.02123.x","volume":"17","author":"F Asano","year":"2012","unstructured":"Asano F, Aoe M, Ohsaki Y, Okada Y, Sasada S, Sato S, et al. Deaths and complications associated with respiratory endoscopy: a survey by the Japan Society for Respiratory Endoscopy in 2010. Respirology. 2012;17:478\u201385.","journal-title":"Respirology"},{"key":"3154_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s00595-023-02711-y","volume":"54","author":"Y Azuma","year":"2024","unstructured":"Azuma Y, Sakamoto S, Homma S, Sakai T, Koezuka S, Kamemura M, et al. Impact of partial pressure of arterial oxygen and radiologic findings on postoperative acute exacerbation of idiopathic interstitial pneumonia in patients with lung cancer. Surg Today. 2024;54:122\u20139.","journal-title":"Surg Today"},{"key":"3154_CR23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4046\/trd.2020.0002","volume":"83","author":"JS Choi","year":"2020","unstructured":"Choi JS, Choi JH, Kim YM, Nam HS, Lee SH, Yoo H, et al. Risk factors for predicting hypoxia in adult patients undergoing bronchoscopy under sedation. Tuberc Respir Dis. 2020;83:312\u201321.","journal-title":"Tuberc Respir Dis"},{"key":"3154_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.55729\/2000-9666.1003","volume":"12","author":"EAS Bergbower","year":"2022","unstructured":"Bergbower EAS, Papadimos TJ, Morris MJ, Phillips GS, Jones GM, Oleson AM, et al. A retrospective analysis of respiratory complications under general anesthesia during EBUS-TBNA. J Community Hosp Intern Med Perspect. 2022;12:19\u201327.","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"3154_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.660800","volume":"8","author":"X Xiaohong","year":"2021","unstructured":"Xiaohong X, Liqiang W, Na L, Ying Z, Yingxue Y, Yuhui Z, et al. Management and prognosis of interstitial lung disease with lung cancer (ILD-LC). Front Mol Biosci. 2021;8:660800.","journal-title":"Front Mol Biosci"},{"key":"3154_CR26","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.athoracsur.2020.06.060","volume":"111","author":"BV Udelsman","year":"2021","unstructured":"Udelsman BV, Madariaga ML, Chang DC, Kozower BD, Gaissert HA. Concordance of clinical and pathologic nodal staging in resectable lung cancer. Ann Thorac Surg. 2021;111:1125\u201332.","journal-title":"Ann Thorac Surg"},{"key":"3154_CR27","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.21873\/invivo.11704","volume":"33","author":"T Fujita","year":"2019","unstructured":"Fujita T, Kuroki T, Hayama N, Takahashi Y, Hara M, Yamada T. Pemetrexed plus platinum for advanced non-small cell lung cancer and interstitial lung disease. In Vivo. 2019;33:2059\u201364.","journal-title":"In Vivo"},{"key":"3154_CR28","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1111\/cas.14217","volume":"110","author":"H Kenmotsu","year":"2019","unstructured":"Kenmotsu H, Yoh K, Mori K, Kubo T, Tamiya A, Shimizu J, et al. Phase II study of nab-paclitaxel plus carboplatin in NSCLC and ILD. Cancer Sci. 2019;110:3738\u201345.","journal-title":"Cancer Sci"},{"key":"3154_CR29","doi-asserted-by":"publisher","first-page":"7013","DOI":"10.2147\/CMAR.S189556","volume":"10","author":"S Igawa","year":"2018","unstructured":"Igawa S, Nishinarita N, Takakura A, Yamada K, Maeda Y, Tamura T. Real-world evaluation of carboplatin plus weekly nab-paclitaxel in NSCLC with ILD. Cancer Manag Res. 2018;10:7013\u20139.","journal-title":"Cancer Manag Res"},{"key":"3154_CR30","doi-asserted-by":"publisher","first-page":"2200369","DOI":"10.1183\/13993003.00380-2022","volume":"60","author":"K Otsubo","year":"2022","unstructured":"Otsubo K, Kishimoto J, Ando M, Kimura H, Sakata T, Sato Y, et al. Nintedanib plus chemotherapy for NSCLC with idiopathic pulmonary fibrosis. Eur Respir J. 2022;60:2200369.","journal-title":"Eur Respir J"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-025-03154-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00595-025-03154-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-025-03154-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T07:48:55Z","timestamp":1774338535000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00595-025-03154-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["3154"],"URL":"https:\/\/doi.org\/10.1007\/s00595-025-03154-3","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest in association with the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}